News View all

April 21, 2017 SPM-011 has been approved for prioritized review under the SAKIGAKE Designation System.
February 28, 2017 A leading-edge project we are collaboratively developing with Sumitomo Heavy Industries, the “Boron Neutron Capture Therapy (BNCT) System” has been approved for prioritized review under the SAKIGAKE Designation System.
July 14, 2016 “Notification of Commencement of Phase II Clinical Trials for Head and Neck Cancer Using Accelerator BNCT” issued.
March 24, 2016 “Concerning Third-Party Share Issuance” publicly released.